SpyGlass Pharma, Inc. (SGP): Total Assets
$115.87M
As of 2025-12-31
$243.43M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $115.87M | +396.9% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $23.32M | n/a | 2026-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | 2025-12-31 | $115.87M | +396.9% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $115.30M | -19.3% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $114.86M | +50.8% |
| Fractyl Health, Inc. (GUTS) | 2025-12-31 | $121.40M | +12.3% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $110.08M | -7.4% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $122.54M | 0.0% |
| Iradimed Corp (IRMD) | 2025-12-31 | $108.78M | +10.6% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $123.63M | +61.4% |
| Alpha Tau Medical Ltd. (DRTS) | 2025-12-31 | $105.65M | +22.6% |
Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗